Endogenous arginase 2 as a potential biomarker for PEGylated arginase 1 treatment in xenograft models of squamous cell lung carcinoma (Q64102494)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30808864 AND SRC:MED&resulttype=core&format=json

25 April 2020

title

Endogenous arginase 2 as a potential biomarker for PEGylated arginase 1 treatment in xenograft models of squamous cell lung carcinoma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30808864 AND SRC:MED&resulttype=core&format=json

25 April 2020

1 reference

1 reference

1 reference

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30808864 AND SRC:MED&resulttype=core&format=json

25 April 2020

author name string

Sze-Kwan Lam

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30808864 AND SRC:MED&resulttype=core&format=json

25 April 2020

Sheng Yan

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30808864 AND SRC:MED&resulttype=core&format=json

25 April 2020

Shi Xu

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30808864 AND SRC:MED&resulttype=core&format=json

25 April 2020

Kin-Pong U

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30808864 AND SRC:MED&resulttype=core&format=json

25 April 2020

Paul Ning-Man Cheng

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30808864 AND SRC:MED&resulttype=core&format=json

25 April 2020

language of work or name

English

0 references

publication date

26 February 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30808864 AND SRC:MED&resulttype=core&format=json

25 April 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30808864 AND SRC:MED&resulttype=core&format=json

25 April 2020

volume

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30808864 AND SRC:MED&resulttype=core&format=json

25 April 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30808864 AND SRC:MED&resulttype=core&format=json

25 April 2020

page(s)

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30808864 AND SRC:MED&resulttype=core&format=json

Creative Commons Attribution 4.0 International

25 April 2020

copyright license

start time

26 February 2019

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

Pegylated arginine deiminase: a novel anticancer enzyme agent

1 reference

https://api.crossref.org/works/10.1038/S41389-019-0128-0

7 January 2021

Preliminary efficacy, safety, pharmacokinetics, pharmacodynamics and quality of life study of pegylated recombinant human arginase 1 in patients with advanced hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1038/S41389-019-0128-0

7 January 2021

Pegylated recombinant human arginase (rhArg-peg5,000mw) inhibits the in vitro and in vivo proliferation of human hepatocellular carcinoma through arginine depletion

1 reference

https://api.crossref.org/works/10.1038/S41389-019-0128-0

7 January 2021

Human recombinant arginase I(Co)-PEG5000 [HuArgI(Co)-PEG5000]-induced arginine depletion is selectively cytotoxic to human acute myeloid leukemia cells

1 reference

https://api.crossref.org/works/10.1038/S41389-019-0128-0

7 January 2021

Recombinant human arginase inhibits the in vitro and in vivo proliferation of human melanoma by inducing cell cycle arrest and apoptosis.

1 reference

https://api.crossref.org/works/10.1038/S41389-019-0128-0

7 January 2021

Growth suppressive effect of pegylated arginase in malignant pleural mesothelioma xenografts.

1 reference

https://api.crossref.org/works/10.1038/S41389-019-0128-0

7 January 2021

Arginase 2 is expressed by human lung cancer, but it neither induces immune suppression, nor affects disease progression

1 reference

https://api.crossref.org/works/10.1038/S41389-019-0128-0

7 January 2021

Arginases I and II: do their functions overlap?

1 reference

https://api.crossref.org/works/10.1038/S41389-019-0128-0

7 January 2021

Wild-type and mutant p53 differentially modulate miR-124/iASPP feedback following pohotodynamic therapy in human colon cancer cell line

1 reference

https://api.crossref.org/works/10.1038/S41389-019-0128-0

7 January 2021

Arginase 2 Suppresses Renal Carcinoma Progression via Biosynthetic Cofactor Pyridoxal Phosphate Depletion and Increased Polyamine Toxicity

1 reference

https://api.crossref.org/works/10.1038/S41389-019-0128-0

7 January 2021

Multicellular tumor spheroids: an underestimated tool is catching up again.

1 reference

https://api.crossref.org/works/10.1038/S41389-019-0128-0

7 January 2021

Contribution of arginase activation to vascular dysfunction in cigarette smoking

1 reference

https://api.crossref.org/works/10.1038/S41389-019-0128-0

7 January 2021

Arginine dependence of acute myeloid leukemia blast proliferation: a novel therapeutic target.

1 reference

https://api.crossref.org/works/10.1038/S41389-019-0128-0

7 January 2021

Recombinant human arginase inhibits proliferation of human hepatocellular carcinoma by inducing cell cycle arrest

1 reference

https://api.crossref.org/works/10.1038/S41389-019-0128-0

7 January 2021

Sensitivity of Colorectal Cancer to Arginine Deprivation Therapy is Shaped by Differential Expression of Urea Cycle Enzymes

1 reference

https://api.crossref.org/works/10.1038/S41389-019-0128-0

7 January 2021

Recombinant human arginase induces apoptosis through oxidative stress and cell cycle arrest in small cell lung cancer

1 reference

https://api.crossref.org/works/10.1038/S41389-019-0128-0

7 January 2021

A subset of well-differentiated hepatocellular carcinomas are Arginase-1 negative.

1 reference

https://api.crossref.org/works/10.1038/S41389-019-0128-0

7 January 2021

Downregulation of thymidylate synthase and E2F1 by arsenic trioxide in mesothelioma.

1 reference

https://api.crossref.org/works/10.1038/S41389-019-0128-0

7 January 2021

Combination effects of arsenic trioxide and fibroblast growth factor receptor inhibitor in squamous cell lung carcinoma

1 reference

https://api.crossref.org/works/10.1038/S41389-019-0128-0

7 January 2021

Generation of a selectively cytotoxic fusion protein against p53 mutated cancers

1 reference

https://api.crossref.org/works/10.1038/S41389-019-0128-0

7 January 2021

Erlotinib-induced autophagy in epidermal growth factor receptor mutated non-small cell lung cancer.

1 reference

https://api.crossref.org/works/10.1038/S41389-019-0128-0

7 January 2021

Estrogen receptor α induces down-regulation of PTEN through PI3-kinase activation in breast cancer cells

1 reference

12 December 2020

Anti-tumor efficacy of a recombinant human arginase in human hepatocellular carcinoma.

1 reference

12 December 2020

Treatment of advanced squamous cell carcinoma of the lung: a review

1 reference

12 December 2020

Inhibition of ornithine decarboxylase 1 facilitates pegylated arginase treatment in lung adenocarcinoma xenograft models

1 reference

12 December 2020

10.1038/S41389-019-0128-0

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30808864 AND SRC:MED&resulttype=core&format=json

Dimensions Publication ID

25 April 2020

0 references

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30808864 AND SRC:MED&resulttype=core&format=json

25 April 2020

PubMed publication ID

30808864

1 reference